| Cell‐penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival L Tabtimmai, P Suphakun, P Srisook, D Kiriwan, S Phanthong, ... Journal of Cellular Biochemistry 120 (10), 18077-18087, 2019 | 34 | 2019 |
| Identification of vinyl sulfone derivatives as EGFR tyrosine kinase inhibitor: in vitro and in silico studies T Aiebchun, P Mahalapbutr, A Auepattanapong, O Khaikate, S Seetaha, ... Molecules 26 (8), 2211, 2021 | 31 | 2021 |
| Evaluation of the anti-malarial activity and cytotoxicity of 2, 4-diamino-pyrimidine-based kinase inhibitors O Phuangsawai, P Beswick, S Ratanabunyong, L Tabtimmai, P Suphakun, ... European Journal of Medicinal Chemistry 124, 896-905, 2016 | 28 | 2016 |
| Biological evaluation and molecular dynamics simulation of chalcone derivatives as epidermal growth factor-tyrosine kinase inhibitors K Sangpheak, L Tabtimmai, S Seetaha, C Rungnim, W Chavasiri, ... Molecules 24 (6), 1092, 2019 | 26 | 2019 |
| Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives K Sanachai, T Aiebchun, P Mahalapbutr, S Seetaha, L Tabtimmai, ... RSC Medicinal Chemistry 12 (3), 430-438, 2021 | 25 | 2021 |
| Anti-HIV-1 reverse transcriptase property of some edible mushrooms in Asia K Choengpanya, S Ratanabunyong, S Seetaha, L Tabtimmai, ... Saudi Journal of Biological Sciences 28 (5), 2807-2815, 2021 | 13 | 2021 |
| Chamuangone from Garcinia cowa leaves inhibits cell proliferation and migration and induces cell apoptosis in human cervical cancer in vitro P Sae-Lim, S Seetaha, L Tabtimmai, P Suphakun, D Kiriwan, ... Journal of Pharmacy and Pharmacology 72 (3), 470-480, 2020 | 12 | 2020 |
| Generation of a nanobody against HER2 tyrosine kinase using phage display library screening for HER2-positive breast cancer therapy development T Lamtha, L Tabtimmai, K Bangphoomi, D Kiriwan, AA Malik, ... Protein Engineering, Design and Selection 34, gzab030, 2021 | 11 | 2021 |
| Anti-feline immunodeficiency virus reverse transcriptase properties of some medicinal and edible mushrooms S Seetaha, S Ratanabunyong, L Tabtimmai, K Choowongkomon, ... Veterinary World 13 (9), 1798, 2020 | 11 | 2020 |
| In silico identification and in vitro validation of nogalamycin N‐oxide (NSC116555) as a potent anticancer compound against non–small‐cell lung cancer cells P Obounchoey, L Tabtimmai, P Suphakun, K Thongkhao, C Eurtivong, ... Journal of cellular biochemistry 120 (3), 3353-3361, 2019 | 10 | 2019 |
| FTIR spectra signatures reveal different cellular effects of EGFR inhibitors on nonsmall cell lung cancer cells L Tabtimmai, P Srisook, B Kuaprasert, K Thumanu, K Choowongkomon Journal of Biophotonics 13 (3), e201960012, 2020 | 9 | 2020 |
| Pharmacophore-based virtual screening and experimental validation of pyrazolone-derived inhibitors toward janus kinases K Sanachai, P Mahalapbutr, K Hengphasatporn, Y Shigeta, S Seetaha, ... ACS omega 7 (37), 33548-33559, 2022 | 8 | 2022 |
| A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach T Lamtha, S Krobthong, Y Yingchutrakul, P Samutrtai, C Gerner, ... Proteome Science 20 (1), 9, 2022 | 8 | 2022 |
| Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies D Kiriwan, S Seetaha, N Jiwacharoenchai, L Tabtimmai, SF Sousa, ... Chemical Biology & Drug Design 99 (3), 456-469, 2022 | 6 | 2022 |
| A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR‐driven cell lines N Jiwacharoenchai, L Tabtimmai, D Kiriwan, C Suwattanasophon, ... Journal of Cellular Biochemistry 123 (2), 248-258, 2022 | 6 | 2022 |
| Discovery of JAK2/3 inhibitors from quinoxalinone-containing compounds K Sanachai, P Mahalapbutr, L Tabtimmai, S Seetaha, T Kittikool, ... ACS omega 7 (37), 33587-33598, 2022 | 4 | 2022 |
| Synchrotron Fourier transform infrared microscopy spectra in cellular effects of Janus Kinase inhibitors on myelofibrosis cancer cells J Siriwaseree, K Sanachai, T Aiebchun, L Tabtimmai, B Kuaprasert, ... ACS omega 7 (26), 22797-22803, 2022 | 3 | 2022 |
| The effect of the EGFR-targeting compound 3-[(4-Phenylpyrimidin-2-yl) amino] benzene-1-sulfonamide (13f) against cholangiocarcinoma cell lines P Samatiwat, L Tabtimmai, P Suphakun, N Jiwacharoenchai, B Toviwek, ... Asian Pacific Journal of Cancer Prevention: APJCP 22 (2), 381, 2021 | 3 | 2021 |
| Generation of a single-chain variable fragment antibody against feline immunoglobulin G for biosensor applications N Rasri, L Tabtimmai, C Kraiya, M Yamabhai, C Sinthuvanich, ... ACS omega 8 (30), 27688-27696, 2023 | 2 | 2023 |
| 4-Aryl-N-phenylpyrimidin-2-amines targeting EGFR-tyrosine kinase attenuated EGFR-expressing cell lines L Tabtimmai, P Supakun, B Toviwek, N Jiwacharoenchai, D Kiriwan, ... European Journal of Medicinal Chemistry Reports 5, 100062, 2022 | 2 | 2022 |
